SIGEA srl

Licensing opportunities: Glycotechnologies for the development of drug targeting systems Innovative drug targeting systems based on glycoconjugates of active drugs for the treatment of hyperproliferative and autoimmune diseases. / New Formulation of Dithranol for the Topical Treatment of Psoriasis A new dithranol-based spray formulation which increases the bioadhesivity, thus reducing the unpleasant staining related to the use of dithranol creams. / Ruthenium Complexes in Cancer Therapy NAMI-A, a ruthenium complex, which has been shown to inhibit metastases by a combination of anti-invasive and anti-angiogenic effects

Activity:

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: